All articles tagged with #pandemic preparedness
Experts warn that bird flu, particularly the expanding reach of H5N1 and related strains, poses a significant but underrecognized threat due to weakened surveillance systems and underfunded health agencies, risking a future pandemic if early warning signals are ignored.
The article warns that despite the ongoing threat of bird flu and its expanding reach into mammals, global disease surveillance systems are underfunded and weakened, risking delayed responses and potential future pandemics, echoing past failures in handling COVID-19.
The article discusses how reduced global influenza sample sharing, partly due to the US withdrawal from WHO, is impairing flu virus tracking and vaccine development, potentially leading to less effective flu shots and decreased pandemic preparedness.
Fifteen Democratic governors have formed a state public health alliance to coordinate efforts on disease monitoring, policy guidance, pandemic preparedness, and supply procurement, aiming to counter turmoil at federal agencies under the Trump administration.
The Ebola outbreak in Kasaï, DRC, highlights the fragility of global health systems, with delayed response and weakened international support risking wider spread. Despite advancements in local capacity, ongoing global infrastructure erosion and resource shortages threaten effective containment, emphasizing the need for sustained international collaboration to prevent future pandemics.
A leading epidemiologist warns that current US pandemic response capacity has been severely diminished, and emphasizes the need for better preparedness, rapid vaccine development, and effective communication to mitigate the impact of future pandemics, which could be even more deadly than COVID-19.
Senator Maria Cantwell criticized Health Secretary Robert Kennedy Jr. during a Senate hearing, accusing him of undermining pandemic preparedness by defunding vaccine research and questioning vaccine safety, raising concerns about the US's readiness for future health crises.
Researchers have replicated a rare genetic mutation that grants near-universal virus immunity in lab animals using mRNA technology, offering a potential short-term protective therapy against various viruses, including COVID-19, though challenges remain in delivery and societal acceptance.
Health Secretary Robert F. Kennedy Jr.'s decision to halt funding for mRNA vaccine development raises concerns among scientists about reduced preparedness for future pandemics and bioterrorism, potentially weakening U.S. national security and technological capabilities.
The Trump administration's decision to cut funding for mRNA vaccine research threatens the US's ability to respond effectively to future pandemics, despite the technology's success in rapidly developing COVID-19 vaccines and its potential to combat evolving pathogens like bird flu.
Scientists have decoded the genome of the 1918 influenza virus from a century-old Swiss specimen, revealing that the virus had already developed key adaptations for human infection at the pandemic's start, providing valuable insights into viral evolution and future pandemic preparedness.
Experts warn that pandemic preparedness in the US has significantly deteriorated under the Trump administration, with weakened health agencies, reduced surveillance, and poor communication increasing the risk of uncontained outbreaks and a future pandemic.
The Trump administration's cancellation of $766 million in mRNA vaccine development contracts is seen as a setback for US biosecurity and pandemic preparedness, potentially leaving the country vulnerable to future threats like bird flu, with experts warning that this could delay vaccine development and response efforts.
The article criticizes the Biden administration's decision to cancel a $600 million contract with Moderna for developing an mRNA-based vaccine against H5N1 bird flu, arguing that this move jeopardizes pandemic preparedness, ignores scientific evidence of vaccine safety, and undermines years of research that could be crucial in preventing a future deadly outbreak.
The Trump administration canceled a nearly $600 million award to Moderna for developing an mRNA bird flu vaccine, ending a key pandemic preparedness effort, though Moderna plans to explore alternative development paths after positive early trial results.